Innovating immunotherapies, transforming tomorrow
Our ImmunoEngine platform combines deep immunology expertise with AI-driven technologies to decode the immune system at scale — from personalized neoantigen discovery for cancer vaccines and T-cell therapies to mRNA codon optimization, ADA risk prediction, and multi-epitope construct design. We enable vaccine developers, biologics innovators, and pharma partners to build safer, more effective immune-based therapies.
Who we serve
For biologics developers
Discover differentiated, high-confidence targets for next-generation biologics with our proprietary AI-powered myNEO technologies.
Discover more →
For vaccine & T-cell developers
Unlock precise, high-immunogenic antigen discovery for immune-driven therapies with our proprietary AI-powered myNEO technologies.
Discover more →
For strategic partners
Explore our proprietary asset library of high-confidence immunotherapy targets available for partnering and licensing.
Discover more →A modular platform powering immune-driven discovery
myNEO offers a modular suite of AI-driven technologies — including myNEO, myRNA, myCONSTRUCT, myADA, myEPITOPE, and mySURFACE — that supports target discovery, prioritization, and optimization for cancer vaccines, biologics, and T-cell therapies. Each solution can be used independently or combined into an integrated end-to-end workflow on ImmunoEngine.
myNEO – Personalized neoantigen discovery
AI-powered, IVD-ready personalized neoantigen discovery for onco immunotherapeutic modalities
myCONSTRUCT – Construct design
Computational construct design enhancing expression and functional performance
mySHARED – Shared MHC-bound target discovery
AI-powered discovery of shared MHC-bound targets for off-the-shelf immunotherapeutic modalities.
myRNA – Codon optimization
Advanced codon optimization engine improving stability and translational efficiency.
mySURFACE – Surfaceome target discovery
AI-powered identification of surface antigens for biological therapeutic modalities.
myADA – ADA risk prediction
Anti-Drug Antibody risk prediction enabling rational, data-driven biologics engineering.
mySELF – Autoimmune target discovery
AI-powered discovery enabling rational design of autoimmune disease therapeutic modalities.
myEPITOPE – Immunogenicity screening
Accurate epitope immunogenicity prediction derisking preclinical validation.
myPATHOGEN – Infectious target discovery
AI-powered discovery of pathogen-derived targets for infectious disease therapeutic modalities.
myINSIGHTS – Large data analysis
Large dataset analysis supporting biomarker identification, response prediction, and decisions.